{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:20Z","timestamp":1791932360675,"version":"4.3.4"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12442-9","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T13:36:44Z","timestamp":1768052204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Access to licenced vaccines for high-threat infectious diseases: a scoping review and interpretive analysis of Ebola virus disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Charlot","family":"Diepvens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan","family":"Guttieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"De Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Vandaele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Guariguata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Decouttere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"12442_CR1","unstructured":"Agency UHS. Guidance: emerging infections: how and why they arise 2023 [Available from: https:\/\/www.gov.uk\/government\/publications\/emerging-infections-characteristics-epidemiology-and-global-distribution\/emerging-infections-how-and-why-they-arise."},{"key":"12442_CR2","unstructured":"Hlip G. A global deal for our pandemic age: increasing frequency of wildlife zoonotic and influenza spillover events 2022 [Available from: https:\/\/pandemic-financing.org\/report\/annexes\/increasing-frequency-of-wildlife-zoonotic-and-influenza-spillover-events\/."},{"issue":"4","key":"12442_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","volume":"20","author":"RE Baker","year":"2022","unstructured":"Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, et al. Infectious disease in an era of global change. Nat Rev Microbiol. 2022;20(4):193\u2013205.","journal-title":"Nat Rev Microbiol"},{"issue":"10377","key":"12442_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0140-6736(22)01597-5","volume":"401","author":"A Elnaiem","year":"2023","unstructured":"Elnaiem A, Mohamed-Ahmed O, Zumla A, Mecaskey J, Charron N, Abakar MF, et al. Global and regional governance of one health and implications for global health security. The Lancet. 2023;401(10377):688\u2013704.","journal-title":"The Lancet"},{"issue":"4","key":"12442_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/JS9.0000000000000175","volume":"109","author":"S Malik","year":"2023","unstructured":"Malik S, Dhasmana A, Bora J, Uniyal P, Slama P, Preetam S, et al. Ebola virus disease (EVD) outbreak re-emergence regulation in East Africa: preparedness and vaccination perspective. Int J Surg. 2023;109(4):1029\u201331.","journal-title":"Int J Surg"},{"issue":"20","key":"12442_CR6","doi-asserted-by":"publisher","first-page":"13113","DOI":"10.3390\/ijerph192013113","volume":"19","author":"P Mulenga-Cilundika","year":"2022","unstructured":"Mulenga-Cilundika P, Ekofo J, Kabanga C, Criel B, Van Damme W, Chenge F. Indirect effects of Ebola virus disease epidemics on health systems in the Democratic Republic of the Congo, Guinea, Sierra Leone and Liberia: a scoping review supplemented with expert interviews. Int J Environ Res And Public Health. 2022;19(20):13113.","journal-title":"Int J Environ Res And Public Health"},{"key":"12442_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26633\/RPSP.2023.74","volume":"47","author":"De Ara\u00fajo","year":"2023","unstructured":"De Ara\u00fajo, De Castro PASV, \u00c1vila IR, Bezerra JMT, Barbosa DS. Effects of public health emergencies of international concern on disease control: a systematic review. Revista Panamericana de Salud P\u00fablica. 2023;47:1.","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"issue":"660","key":"12442_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/ej\/uead103","volume":"134","author":"B Eichengreen","year":"2024","unstructured":"Eichengreen B, Saka O, Aksoy CG. The political scar of epidemics. The Econ J. 2024;134(660):1683\u2013700.","journal-title":"The Econ J"},{"key":"12442_CR9","first-page":"121","volume-title":"Gender-based violence among adolescent girls and young women: a neglected consequence of the West African Ebola outbreak","author":"MA Onyango","year":"2019","unstructured":"Onyango MA, Resnick K, Davis A, Shah RR. Gender-based violence among adolescent girls and young women: a neglected consequence of the West African Ebola outbreak. Springer International Publishing; 2019. p. 121\u201332."},{"key":"12442_CR10","unstructured":"CEPI. Priority diseases 2024 [Available from: https:\/\/cepi.net\/priority-diseases."},{"key":"12442_CR11","unstructured":"WHO. Prioritizing diseases for research and development in emergency contexts 2024 [Available from: https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts."},{"key":"12442_CR12","unstructured":"CDC A. Risk ranking and prioritization of epidemic-prone diseases. Manuals, guidelines & frameworks. Ethiopia: Africa CDC, division hepar. 2023 2023 February 26."},{"key":"12442_CR13","unstructured":"ICTV. Virus taxonomy family filoviridae genus Orthoebolavirus 2025 [Available from: https:\/\/ictv.global\/report\/chapter\/filoviridae\/filoviridae\/orthoebolavirus."},{"key":"12442_CR14","doi-asserted-by":"crossref","unstructured":"Biedenkopf N, Bukreyev A, Chandran K, Di Paola N, Formenty PBH, Griffiths A, et al. Renaming of genera ebolavirus and marburgvirus to Orthoebolavirus and orthomarburgvirus, respectively, and introduction of binomial species names within family filoviridae. Archiv Virol. 2023;168(8).","DOI":"10.1007\/s00705-023-05834-2"},{"issue":"8","key":"12442_CR15","doi-asserted-by":"publisher","first-page":"e19036","DOI":"10.1016\/j.heliyon.2023.e19036","volume":"9","author":"HA Hussein","year":"2023","unstructured":"Hussein HA. Brief review on ebola virus disease and one health approach. Heliyon. 2023;9(8):e19036.","journal-title":"Heliyon"},{"key":"12442_CR16","doi-asserted-by":"crossref","unstructured":"Jacob ST, Crozier I, Fischer WA, Hewlett A, Kraft CS, Vega M-ADL, et al. Ebola virus disease. Nat Rev Disease Primers. 2020;6(1).","DOI":"10.1038\/s41572-020-0147-3"},{"key":"12442_CR17","unstructured":"CDC. How Ebola disease spreads 2024. Available from: https:\/\/www.cdc.gov\/ebola\/causes\/index.html."},{"key":"12442_CR18","unstructured":"Park C. Traditional funeral and burial rituals and Ebola outbreaks in West Africa: a narrative review of causes and strategy interventions. J Health And Soc Sci. 2020;073\u201390."},{"issue":"9","key":"12442_CR19","doi-asserted-by":"publisher","first-page":"e1617","DOI":"10.1016\/S2214-109X(25)00220-7","volume":"13","author":"F Checchi","year":"2025","unstructured":"Checchi F, Eamer G, Katshitshi J, Robles Dios L, Kai A, Warsame A. Effect of a safe and dignified burial intervention on Ebola virus transmission in the eastern Democratic Republic of the Congo, 2018-19. A propensity score analysis. The Lancet Global Health. 2025;13(9):e1617\u201326.","journal-title":"The Lancet Global Health"},{"issue":"1","key":"12442_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jiph.2023.10.020","volume":"17","author":"J Izudi","year":"2024","unstructured":"Izudi J, Bajunirwe F. Case fatality rate for Ebola disease, 1976-2022. A meta-analysis of global data. J Infect And Public Health. 2024;17(1):25\u201334.","journal-title":"J Infect And Public Health"},{"issue":"6","key":"12442_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1473-3099(23)00819-8","volume":"24","author":"RM Coulborn","year":"2024","unstructured":"Coulborn RM, Bastard M, Peyraud N, Gignoux E, Luquero F, Guai B, et al. Case fatality risk among individuals vaccinated with rVSV\u0394G-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo. The Lancet Infect Dis. 2024;24(6):602\u201310.","journal-title":"The Lancet Infect Dis"},{"key":"12442_CR22","unstructured":"CDC. Outbreak History. 2024. https:\/\/www.cdc.gov\/ebola\/outbreaks\/index.html. updated May 6, 2024. Available from."},{"issue":"12","key":"12442_CR23","doi-asserted-by":"publisher","first-page":"e1010078","DOI":"10.1371\/journal.ppat.1010078","volume":"17","author":"C Woolsey","year":"2021","unstructured":"Woolsey C, Geisbert TW. Current state of Ebola virus vaccines: a snapshot. PLoS Pathog. 2021;17(12):e1010078.","journal-title":"PLoS Pathog"},{"key":"12442_CR24","doi-asserted-by":"crossref","unstructured":"Redding DW, Atkinson PM, Cunningham AA, Lo Iacono G, Moses LM, Wood JLN, et al. Impacts of environmental and socio-economic factors on emergence and epidemic potential of Ebola in Africa. Nat Commun. 2019;10(1).","DOI":"10.1038\/s41467-019-12499-6"},{"issue":"Supplement_7","key":"12442_CR25","doi-asserted-by":"publisher","first-page":"S465","DOI":"10.1093\/infdis\/jiad352","volume":"228","author":"SD Judson","year":"2023","unstructured":"Judson SD, Munster VJ. The multiple origins of Ebola disease outbreaks. The J Infect Dis. 2023;228(Supplement_7):S465\u201373.","journal-title":"The J Infect Dis"},{"issue":"16","key":"12442_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.15585\/mmwr.mm7316a1","volume":"73","author":"R Kallay","year":"2024","unstructured":"Kallay R, Doshi RH, Muhoza P, Choi MJ, Legand A, Aberle-Grasse E, et al. Use of Ebola vaccines - worldwide, 2021-2023. Morbidity And Mortal Wkly Report. 2024;73(16):360\u201364.","journal-title":"Morbidity And Mortal Wkly Report"},{"key":"12442_CR27","unstructured":"Lewis I. Market & supply update: ebola vaccine. in: Unicef, editor. 2023. https:\/\/www.unicef.org\/supply\/media\/18971\/file\/VIC-MarketUpdate-Poster-Ebola-2023.pdf."},{"key":"12442_CR28","unstructured":"WHO. Ebola Virus Disease Vaccines. 2020 [Available from: https:\/\/www.who.int\/teams\/regulation-prequalification\/eul\/ebola-vaccines."},{"issue":"3","key":"12442_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/vaccines9030190","volume":"9","author":"J Wolf","year":"2021","unstructured":"Wolf J, Jannat R, Dubey S, Troth S, Onorato MT, Coller B-A, et al. Development of pandemic vaccines: ERVEBO case study. Vaccines. 2021;9(3):190.","journal-title":"Vaccines"},{"issue":"1","key":"12442_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1358\/dot.2021.57.1.3233361","volume":"57","author":"MC Kasereka","year":"2021","unstructured":"Kasereka MC, Mumtaz Z, Hawkes MT. Recombinant vesicular stomatitis virus expressing Ebola virus glycoprotein (rVSV-EBOV), a new Ebola vaccine. Drugs of Today. 2021;57(1):27.","journal-title":"Drugs of Today"},{"key":"12442_CR31","unstructured":"World Health Organization. Ebola vaccine stockpiles 2021 [Available from: https:\/\/www.who.int\/groups\/icg\/ebola-virus-disease\/ebola-stockpiles."},{"issue":"1","key":"12442_CR32","first-page":"100038","volume":"2","author":"P Shears","year":"2020","unstructured":"Shears P, Garavan C. The 2018\/19 Ebola epidemic the Democratic Republic of the Congo (DRC): epidemiology, outbreak control, and conflict. Infect Prev In Pract. 2020;2(1):100038.","journal-title":"Infect Prev In Pract"},{"key":"12442_CR33","unstructured":"Ebola [Internet]. 2025. Available from: https:\/\/app.powerbi.com\/view?r=eyJrIjoiZjU2NjA3ZDUtOWFhNS00YTYwLTk3OWYtYzQ3YWViYTM3NzA5IiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9."},{"key":"12442_CR34","unstructured":"SAGE. Extraordinary meeting of the Strategic Advisory group of Experts on immunization on Ebola vaccination, May, 2024: conclusions and recommendations. World Health Organ, Immun vabi, Strateg Advisory Group of Experts On Immun. 2024, 5 July 2024. Report No.: ISBN: 978 92 4 009398 0 Contract No.: 27."},{"key":"12442_CR35","unstructured":"Gavi. Gavi announces launch of preventive Ebola, routine multivalent meningitis, human rabies, and hepatitis B birth dose vaccination programmes 2024 [Available from: https:\/\/www.gavi.org\/news\/media-room\/gavi-announces-launch-preventive-ebola-routine-multivalent-meningitis-human-rabies-hep-b-vaccination-programmes."},{"key":"12442_CR36","unstructured":"CEPI. Priority pathogens 2025 [Available from: https:\/\/cepi.net\/priority-pathogens."},{"key":"12442_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coph.2021.06.008","volume":"60","author":"AR Sharma","year":"2021","unstructured":"Sharma AR, Lee Y-H, Nath S, Lee S-S. Recent developments and strategies of Ebola virus vaccines. Curr Opin In Pharmacol. 2021;60:46\u201353.","journal-title":"Curr Opin In Pharmacol"},{"key":"12442_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijid.2018.06.022","volume":"74","author":"L Gross","year":"2018","unstructured":"Gross L, Lhomme E, Pasin C, Richert L, Thiebaut R. Ebola vaccine development: systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination. Int J Infect Dis. 2018;74:83\u201396.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"12442_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2217\/fmb-2019-0237","volume":"15","author":"BE Bache","year":"2020","unstructured":"Bache BE, Grobusch MP, Agnandji ST. Safety, Immunogenicity and risk-benefit analysis of rVSV-\u0394G-ZEBOV-GP (V920) Ebola vaccine in phase I-III clinical trials across regions. Future Microbiol. 2020;15(2):85\u2013106.","journal-title":"Future Microbiol"},{"issue":"1","key":"12442_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-virology-092818-015708","volume":"6","author":"W Furuyama","year":"2019","unstructured":"Furuyama W, Marzi A. Ebola virus: pathogenesis and countermeasure development. Annu Rev Virol. 2019;6(1):435\u201358.","journal-title":"Annu Rev Virol"},{"issue":"1","key":"12442_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev-micro-090817-062414","volume":"72","author":"H Feldmann","year":"2018","unstructured":"Feldmann H, Feldmann F, Marzi A. Ebola: lessons on vaccine development. Annu Rev Microbiol. 2018;72(1):423\u201346.","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"12442_CR42","first-page":"e220055","volume":"11","author":"C Patel","year":"2023","unstructured":"Patel C, Rendell N, Sargent GM, Ali A, Morgan C, Fields R, et al. Measuring national immunization system performance: a systematic assessment of Available Resources. Global Health: Sci Pract. 2023;11(3):e220055.","journal-title":"Global Health: Sci Pract"},{"issue":"7","key":"12442_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann of Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann of Intern Med"},{"key":"12442_CR44","doi-asserted-by":"crossref","unstructured":"Van Den Akker OR, G-Jy P, Bakker CJ, Carlsson R, Coles NA, Corker KS, et al. Increasing the transparency of systematic reviews: presenting a generalized registration form. Systematic Rev. 2023;12(1).","DOI":"10.1186\/s13643-023-02281-7"},{"issue":"3","key":"12442_CR45","doi-asserted-by":"publisher","first-page":"520","DOI":"10.11124\/JBIES-22-00123","volume":"21","author":"D Pollock","year":"2022","unstructured":"Pollock D, Peters MDJ, Khalil H, McInerney P, Alexander L, Tricco AC, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evidence Synth. 2022;21(3):520\u201332.","journal-title":"JBI Evidence Synth"},{"key":"12442_CR46","volume-title":"Everybody\u2019s business: strengthening health systems to improve health outcomes: WHO\u2019s framework for action","author":"World Health Organization","year":"2007","unstructured":"World Health Organization. Everybody\u2019s business: strengthening health systems to improve health outcomes: WHO\u2019s framework for action. Geneva: World Health Organization; 2007."},{"issue":"2","key":"12442_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res In Phychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res In Phychol"},{"key":"12442_CR48","doi-asserted-by":"crossref","unstructured":"Dixon-Woods M, Cavers D, Agarwal S, Annandale E, Arthur A, Harvey J, et al. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006;6(1).","DOI":"10.1186\/1471-2288-6-35"},{"key":"12442_CR49","doi-asserted-by":"crossref","unstructured":"Noblit G, Meta-Ethnography HR. 1988.","DOI":"10.4135\/9781412985000"},{"issue":"6","key":"12442_CR50","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/vaccines11061120","volume":"11","author":"LA Parish","year":"2023","unstructured":"Parish LA, Stavale EJ, Houchens CR, Wolfe DN. Developing vaccines to improve preparedness for filovirus outbreaks: the perspective of the USA Biomedical advanced research and development authority (BARDA). Vaccines. 2023;11(6):1120.","journal-title":"Vaccines"},{"key":"12442_CR51","doi-asserted-by":"crossref","unstructured":"Abdul-Rahman T, Lawal L, Meale E, Ajetunmobi OA, Toluwalashe S, Alao UH, et al. Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: a state of arts review. J Med Virol. 2023;95(8).","DOI":"10.1002\/jmv.28986"},{"issue":"4","key":"12442_CR52","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41591-021-01313-w","volume":"27","author":"DG Bausch","year":"2021","unstructured":"Bausch DG. The need for a new strategy for Ebola vaccination. Nat Med. 2021;27(4):580\u201381.","journal-title":"Nat Med"},{"issue":"7","key":"12442_CR53","doi-asserted-by":"publisher","first-page":"e0000429","DOI":"10.1371\/journal.pgph.0000429","volume":"2","author":"GK Kyomba","year":"2022","unstructured":"Kyomba GK, Kiyombo GM, Gr\u00e9pin KA, Mayaka SM, Mambu TN-M, Hategeka C, et al. Assessing routine health information system performance during the tenth outbreak of Ebola virus disease (2018-2020) in the Democratic Republic of the Congo: a qualitative study in North Kivu. PLoS Global Public Health. 2022;2(7):e0000429.","journal-title":"PLoS Global Public Health"},{"key":"12442_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2021.03.008","volume":"71","author":"O Tomori","year":"2021","unstructured":"Tomori O, Kolawole MO. Ebola virus disease: current vaccine solutions. Curr Opin In Immunol. 2021;71:27\u201333.","journal-title":"Curr Opin In Immunol"},{"key":"12442_CR55","doi-asserted-by":"crossref","unstructured":"Soeters HM, Doshi RH, Fleming M, Adegoke OJ, Ajene U, Aksnes BN, et al. CDC\u2019s COVID-19 International vaccine implementation and evaluation program and Lessons from earlier vaccine introductions. Emerging Infect Dis. 2022;28(13).","DOI":"10.3201\/eid2813.212123"},{"issue":"4","key":"12442_CR56","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/infdis\/jiz520","volume":"222","author":"DG Bausch","year":"2020","unstructured":"Bausch DG, Piot P. Ebola vaccines: biomedical advances, human rights challenges. The J Infect Dis. 2020;222(4):521\u201324.","journal-title":"The J Infect Dis"},{"issue":"19","key":"12442_CR57","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJMra1901594","volume":"382","author":"H Feldmann","year":"2020","unstructured":"Feldmann H, Sprecher A, Geisbert TW. Ebola. N Engl J Med. 2020;382(19):1832\u201342.","journal-title":"N Engl J Med"},{"issue":"4","key":"12442_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1473-3099(20)30056-6","volume":"20","author":"RS Dhillon","year":"2020","unstructured":"Dhillon RS, Srikrishna D, Chowell G. Getting to zero in the DR Congo Ebola outbreak. The Lancet Infect Dis. 2020;20(4):395\u201397.","journal-title":"The Lancet Infect Dis"},{"issue":"14","key":"12442_CR59","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1016\/j.vaccine.2020.02.044","volume":"38","author":"MC Kasereka","year":"2020","unstructured":"Kasereka MC, Ericson AD, Conroy AL, Tumba L, Mwesha OD, Hawkes MT. Prior vaccination with recombinant vesicular stomatitis virus - Zaire ebolavirus vaccine is associated with improved survival among patients with ebolavirus infection. Vaccine. 2020;38(14):3003\u201307.","journal-title":"Vaccine"},{"issue":"7945","key":"12442_CR60","doi-asserted-by":"publisher","first-page":"613\u2013","DOI":"10.1038\/d41586-023-00184-0","volume":"613","author":"HK Bosa","year":"2023","unstructured":"Bosa HK. Don\u2019t wait for an Ebola outbreak to vaccinate people against it. Nature. 2023;613(7945):613\u2013.","journal-title":"Nature"},{"issue":"10226","key":"12442_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(20)30495-5","volume":"395","author":"J Zarocostas","year":"2020","unstructured":"Zarocostas J. Hope for the Ebola outbreak in DR Congo. The Lancet. 2020;395(10226):773.","journal-title":"The Lancet"},{"key":"12442_CR62","doi-asserted-by":"crossref","unstructured":"Taylor L. Ivory Coast rolls out Ebola vaccine after first confirmed case since 1994. BMJ. 2021: n 2047.","DOI":"10.1136\/bmj.n2047"},{"issue":"8","key":"12442_CR63","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/vaccines10081213","volume":"10","author":"I Crozier","year":"2022","unstructured":"Crozier I, Britson KA, Wolfe DN, Klena JD, Hensley LE, Lee JS, et al. The evolution of Medical countermeasures for Ebola virus disease: lessons Learned and next steps. Vaccines. 2022;10(8):1213.","journal-title":"Vaccines"},{"key":"12442_CR64","doi-asserted-by":"crossref","unstructured":"Doshi RH, Garbern SC, Kulkarni S, Perera SM, Fleming MK, Muhayangabo RF, et al. Ebola vaccine uptake and attitudes among healthcare workers in North Kivu, Democratic Republic of the Congo, 2021. Front Public Health. 2023;11.","DOI":"10.3389\/fpubh.2023.1080700"},{"key":"12442_CR65","doi-asserted-by":"crossref","unstructured":"Pare BC, Camara AM, Camara A, Kourouma M, Enogo K, Camara MS, et al. Ebola outbreak in Guinea, 2021: clinical care of patients with Ebola virus disease. South Afr J Infect Dis. 2023;38(1).","DOI":"10.4102\/sajid.v38i1.454"},{"issue":"1","key":"12442_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.pcl.2021.08.006","volume":"69","author":"T Puthanakit","year":"2022","unstructured":"Puthanakit T, Anugulruengkitt S, Jantarabenjakul W. Prevention of emerging infections in children. Pediatr Clinics of North Am. 2022;69(1):185\u2013202.","journal-title":"Pediatr Clinics of North Am"},{"issue":"13","key":"12442_CR67","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ajhp\/zxab139","volume":"78","author":"Ebola Zaire vaccine live","year":"2021","unstructured":"Ebola Zaire vaccine live. Am J Health-System Pharm. 2021;78(13):1157\u201359.","journal-title":"Am J Health-System Pharm"},{"issue":"1","key":"12442_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7001a1","volume":"70","author":"MJ Choi","year":"2021","unstructured":"Choi MJ, Cossaboom CM, Whitesell AN, Dyal JW, Joyce A, Morgan RL, et al. Use of Ebola vaccine: recommendations of the Advisory Committee on immunization practices, United States, 2020. MMWR Recommendations And Rep. 2021;70(1):1\u201312.","journal-title":"MMWR Recommendations And Rep"},{"issue":"8","key":"12442_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm7108a2","volume":"71","author":"JH Malenfant","year":"2022","unstructured":"Malenfant JH, Joyce A, Choi MJ, Cossaboom CM, Whitesell AN, Harcourt BH, et al. Use of Ebola vaccine: expansion of recommendations of the Advisory Committee on immunization practices to include two additional populations - United States, 2021. MMWR Morbidity And Mortal Wkly Report. 2022;71(8):290\u201392.","journal-title":"MMWR Morbidity And Mortal Wkly Report"},{"issue":"13","key":"12442_CR70","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa2024670","volume":"384","author":"P Mbala-Kingebeni","year":"2021","unstructured":"Mbala-Kingebeni P, Pratt C, Mutafali-Ruffin M, Pauthner MG, Bile F, Nkuba-Ndaye A, et al. Ebola virus transmission initiated by relapse of systemic Ebola virus disease. N Engl J Med. 2021;384(13):1240\u201347.","journal-title":"N Engl J Med"},{"issue":"12","key":"12442_CR71","doi-asserted-by":"publisher","first-page":"e1455","DOI":"10.1016\/S2214-109X(20)30454-X","volume":"8","author":"RH Doshi","year":"2020","unstructured":"Doshi RH, Fleming M, Mukoka AK, Carter RJ, Hyde TB, Choi M, et al. Vaccination of contacts of Ebola virus disease survivors to prevent further transmission. The Lancet Global Health. 2020;8(12):e1455\u20136.","journal-title":"The Lancet Global Health"},{"issue":"13","key":"12442_CR72","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJMp2025512","volume":"383","author":"A Christie","year":"2020","unstructured":"Christie A, Neatherlin JC, Nichol ST, Beach M, Redfield RR. Ebola response priorities in the time of covid-19. N Engl J Med. 2020;383(13):1202\u201304.","journal-title":"N Engl J Med"},{"key":"12442_CR73","doi-asserted-by":"crossref","unstructured":"Ye W, Ye C, Li J, Lei Y, Zhang F. Lessons from Pasteur may help prevent the deadly relapse of Ebola in patients: using contingency vaccination to avoid Ebola relapse in immune-privileged organs. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1060481"},{"key":"12442_CR74","doi-asserted-by":"crossref","unstructured":"Rupani N, Ngole ME, Lee JA, Aluisio AR, Gainey M, Perera SM, et al. Effect of recombinant vesicular stomatitis virus-Zaire Ebola virus vaccination on Ebola virus disease illness and death, Democratic Republic of the Congo. Emerging Infect Dis. 2022;28(6).","DOI":"10.3201\/eid2806.212223"},{"issue":"2","key":"12442_CR75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clp.2021.03.006","volume":"48","author":"DSM A","year":"2021","unstructured":"A DSM, Ervin E, Ebola CA. Dengue, Chikungunya, and Zika Infections in Neonates and Infants. Clin Perinatology. 2021;48(2):311\u201329.","journal-title":"Clin Perinatology"},{"key":"12442_CR76","doi-asserted-by":"crossref","unstructured":"Saied AA, Metwally AA, Dhawan M, Choudhary OP, Aiash H. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. EMBO Mol Med. 2022;14(8).","DOI":"10.15252\/emmm.202216287"},{"key":"12442_CR77","doi-asserted-by":"crossref","unstructured":"Malange VNE, Hedermann G, Lausten-Thomsen U, Hoffmann S, Voldstedlund M, Aabakke AJM, et al. The perinatal health challenges of emerging and re-emerging infectious diseases: a narrative review. Front Public Health. 2023;10.","DOI":"10.3389\/fpubh.2022.1039779"},{"issue":"1","key":"12442_CR78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.vaccine.2019.01.011","volume":"39","author":"CB Krubiner","year":"2021","unstructured":"Krubiner CB, Faden RR, Karron RA, Little MO, Lyerly AD, Abramson JS, et al. Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response. Vaccine. 2021;39(1):85\u2013120.","journal-title":"Vaccine"},{"key":"12442_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejogrb.2020.12.037","volume":"258","author":"K Appiah-Sakyi","year":"2021","unstructured":"Appiah-Sakyi K, Mohan M, Konje JC. Ebola infection in pregnancy, an ongoing challenge for both the global health expert and the pregnant woman-A review. Eur J Obstet Gynecology And Reprod Biol. 2021;258:111\u201317.","journal-title":"Eur J Obstet Gynecology And Reprod Biol"},{"issue":"9","key":"12442_CR80","doi-asserted-by":"publisher","first-page":"e0286843","DOI":"10.1371\/journal.pone.0286843","volume":"18","author":"D Philpott","year":"2023","unstructured":"Philpott D, Rupani N, Gainey M, Mbong EN, Musimwa PI, Perera SM, et al. Maternal, fetal, and perinatal outcomes among pregnant women admitted to an Ebola treatment center in the Democratic Republic of Congo, 2018-2020. PLoS One. 2023;18(9):e0286843.","journal-title":"PLoS One"},{"issue":"11","key":"12442_CR81","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/infdis\/jiab243","volume":"224","author":"BE Mahon","year":"2021","unstructured":"Mahon BE, Simon J, Widdowson M-A, Samai M, Rogier E, Legardy-Williams J, et al. Baseline Asymptomatic malaria infection and Immunogenicity of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein. The J Infect Dis. 2021;224(11):1907\u201315.","journal-title":"The J Infect Dis"},{"issue":"12","key":"12442_CR82","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.vaccine.2020.02.002","volume":"38","author":"H Davis","year":"2020","unstructured":"Davis H, Dow T, Isopi L, Blue JT. Examination of the effect of agitation on the potency of the Ebola Zaire vaccine rVSV\u0394G-ZEBOV-GP. Vaccine. 2020;38(12):2643\u201345.","journal-title":"Vaccine"},{"issue":"2","key":"12442_CR83","first-page":"332","volume":"9","author":"G Earle-Richardson","year":"2021","unstructured":"Earle-Richardson G, Erlach E, Walz V, Baggio O, Kurnit M, Camara CA, et al. New mixed methods approach for monitoring community perceptions of Ebola and response efforts in the Democratic Republic of the Congo. Global Health: Sci Pract. 2021;9(2):332\u201343.","journal-title":"Global Health: Sci Pract"},{"issue":"sup1","key":"12442_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2021.2002092","volume":"24","author":"M Obeng-Kusi","year":"2021","unstructured":"Obeng-Kusi M, Habila MA, Roe DJ, Erstad B, Abraham I. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries. J Med Econ. 2021;24(sup1):1\u201313.","journal-title":"J Med Econ"},{"issue":"1","key":"12442_CR85","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/13696998.2022.2091858","volume":"25","author":"M Obeng-Kusi","year":"2022","unstructured":"Obeng-Kusi M, Erstad B, Roe DJ, Abraham I. Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis. J Med Econ. 2022;25(1):894\u2013902.","journal-title":"J Med Econ"},{"issue":"4","key":"12442_CR86","doi-asserted-by":"publisher","first-page":"e0230406","DOI":"10.1371\/journal.pone.0230406","volume":"15","author":"R Potluri","year":"2020","unstructured":"Potluri R, Kumar A, Maheshwari V, Smith C, Oriol Mathieu V, Luhn K, et al. Impact of prophylactic vaccination strategies on Ebola virus transmission: a modeling analysis. PLoS One. 2020;15(4):e0230406.","journal-title":"PLoS One"},{"issue":"3","key":"12442_CR87","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.vaccine.2022.11.036","volume":"41","author":"D Bisanzio","year":"2023","unstructured":"Bisanzio D, Davis AE, Talbird SE, Van Effelterre T, Metz L, Gaudig M, et al. Targeted preventive vaccination campaigns to reduce Ebola outbreaks: an individual-based modeling study. Vaccine. 2023;41(3):684\u201393.","journal-title":"Vaccine"},{"key":"12442_CR88","doi-asserted-by":"crossref","unstructured":"Potluri R, Kumar A, Oriol-Mathieu V, Van Effelterre T, Metz L, Bhandari H. Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo. BMC Infect Dis. 2022;22(1).","DOI":"10.1186\/s12879-022-07723-6"},{"issue":"4","key":"12442_CR89","doi-asserted-by":"publisher","first-page":"e0283721","DOI":"10.1371\/journal.pone.0283721","volume":"18","author":"LTR Morrison","year":"2023","unstructured":"Morrison LTR, Anderson B, Brower A, Talbird SE, Buell N, Macdonald PDM, et al. Macroeconomic impact of Ebola outbreaks in Sub-Saharan Africa and potential mitigation of GDP loss with prophylactic Ebola vaccination programs. PLoS One. 2023;18(4):e0283721.","journal-title":"PLoS One"},{"issue":"3","key":"12442_CR90","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2478\/jtim-2023-0100","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S, Waheed Y. Tracing down the updates on Ebola virus surges: an update on anti-ebola therapeutic strategies. J Transl Intern Med. 2023;11(3):216\u201325.","journal-title":"J Transl Intern Med"},{"key":"12442_CR91","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.idm.2020.10.003","volume":"5","author":"SMC Abo","year":"2020","unstructured":"Abo SMC, Smith R. Modelling the daily risk of Ebola in the presence and absence of a potential vaccine. Infect Disease Modell. 2020;5:905\u201317.","journal-title":"Infect Disease Modell"},{"key":"12442_CR92","doi-asserted-by":"publisher","first-page":"104562","DOI":"10.1016\/j.ebiom.2023.104562","volume":"91","author":"C McLean","year":"2023","unstructured":"McLean C, Barry H, Kieh M, Anywaine Z, Tapima Rogers B, Doumbia S, et al. Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated filovirus animal nonclinical group enzyme-linked immunosorbent assay in a single accredited laboratory. eBiomedicine. 2023;91:104562.","journal-title":"eBiomedicine"},{"issue":"9","key":"12442_CR93","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/vaccines10091446","volume":"10","author":"B-A Coller","year":"2022","unstructured":"Coller B-AG, Lapps W, Yunus M, Bruno S, Eichberg MJ, Lee AW-T, et al. Lessons Learned from the development and roll-out of the rVSV\u0394G-ZEBOV-GP Zaire ebolavirus vaccine to inform Marburg virus and Sudan ebolavirus vaccines. Vaccines. 2022;10(9):1446.","journal-title":"Vaccines"},{"issue":"26","key":"12442_CR94","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2200072","volume":"387","author":"PREVAC Study Team","year":"2022","unstructured":"PREVAC Study Team. Randomized Trial of vaccines for Zaire Ebola virus disease. N Engl J Med. 2022;387(26):2411\u201324.","journal-title":"N Engl J Med"},{"key":"12442_CR95","doi-asserted-by":"crossref","unstructured":"Jombart T, Jarvis CI, Mesfin S, Tabal N, Mossoko M, Mpia LM, et al. The cost of insecurity: from flare-up to control of a major Ebola virus disease hotspot during the outbreak in the Democratic Republic of the Congo, 2019. Eurosurveillance. 2020;25(2).","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900735"},{"issue":"22","key":"12442_CR96","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1016\/j.vaccine.2020.03.044","volume":"38","author":"MF Jalloh","year":"2020","unstructured":"Jalloh MF, Wallace AS, Bunnell RE, Carter RJ, Redd JT, Nur SA, et al. Ebola vaccine? Family first! Evidence from using a brief measure on Ebola vaccine demand in a national household survey during the outbreak in Sierra Leone. Vaccine. 2020;38(22):3854\u201361.","journal-title":"Vaccine"},{"issue":"5","key":"12442_CR97","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/vaccines11050973","volume":"11","author":"SC Garbern","year":"2023","unstructured":"Garbern SC, Perera SM, Mbong EN, Kulkarni S, Fleming MK, Ombeni AB, et al. COVID-19 vaccine perceptions among Ebola-affected communities in North Kivu, Democratic Republic of the Congo, 2021. Vaccines. 2023;11(5):973.","journal-title":"Vaccines"},{"issue":"7","key":"12442_CR98","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/vaccines10071066","volume":"10","author":"L Peckeu-Abboud","year":"2022","unstructured":"Peckeu-Abboud L, Mangoni P, Chammam K, Kwete P, Mutombo Lupola P, Vanlerberghe V, et al. Drivers of routine and outbreak vaccination uptake in the Western Democratic Republic of Congo: an exploratory study in Ten health zones. Vaccines. 2022;10(7):1066.","journal-title":"Vaccines"},{"key":"12442_CR99","doi-asserted-by":"crossref","unstructured":"Truong J, Bakshi S, Wasim A, Ahmad M, Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health Promot Int. 2022;37(1).","DOI":"10.1093\/heapro\/daab105"},{"issue":"2","key":"12442_CR100","doi-asserted-by":"publisher","first-page":"e2147462","DOI":"10.1001\/jamanetworkopen.2021.47462","volume":"5","author":"PN Pham","year":"2022","unstructured":"Pham PN, Sharma M, Bindu KK, Zikomangane P, Nethery RC, Nilles E, et al. Protective behaviors associated with Gender during the 2018\u20132020 Ebola outbreak in eastern Democratic Republic of the Congo. JAMA Network Open. 2022;5(2):e2147462.","journal-title":"JAMA Network Open"},{"issue":"2","key":"12442_CR101","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/infdis\/jiac283","volume":"227","author":"J Nyombayire","year":"2023","unstructured":"Nyombayire J, Ingabire R, Magod B, Mazzei A, Mazarati J-B, Noben J, et al. Monitoring of adverse events in recipients of the 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in the UMURINZI Ebola vaccination campaign. The J Infect Dis. 2023;227(2):268\u201377.","journal-title":"The J Infect Dis"},{"issue":"6","key":"12442_CR102","doi-asserted-by":"publisher","first-page":"e011907","DOI":"10.1136\/bmjgh-2023-011907","volume":"8","author":"M Keita","year":"2023","unstructured":"Keita M, Polonsky JA, Ahuka-Mundeke S, Ilumbulumbu MK, Dakissaga A, Boiro H, et al. A community-based contact isolation strategy to reduce the spread of Ebola virus disease: an analysis of the 2018\u20132020 outbreak in the Democratic Republic of the Congo. BMJ Global Health. 2023;8(6):e011907.","journal-title":"BMJ Global Health"},{"key":"12442_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/dmp.2022.275","volume":"17","author":"BCA Van Stekelenburg","year":"2023","unstructured":"Van Stekelenburg BCA, De Cauwer H, Barten DG, Mortelmans LJ. Attacks on health care workers in historical pandemics and COVID-19. Disaster Med And Public Health Preparedness. 2023;17:1\u201323.","journal-title":"Disaster Med And Public Health Preparedness"},{"issue":"7","key":"12442_CR104","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/vaccines9070709","volume":"9","author":"E Talarek","year":"2021","unstructured":"Talarek E, Warzecha J, Banasiuk M, Banaszkiewicz A. Influenza vaccination coverage and intention to receive hypothetical Ebola and COVID-19 vaccines among Medical students. Vaccines. 2021;9(7):709.","journal-title":"Vaccines"},{"issue":"5","key":"12442_CR105","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/01459740.2022.2097908","volume":"41","author":"MV James","year":"2022","unstructured":"James MV, Lees SS. \u201cAre you sure it\u2019s not the corona vaccine?\u201d an Ebola vaccine Trial during COVID-19 in DRC. Med Anthropol. 2022;41(5):503\u201317.","journal-title":"Med Anthropol"},{"issue":"9","key":"12442_CR106","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1080\/21645515.2021.1920872","volume":"17","author":"P Mc Kenna","year":"2021","unstructured":"Mc Kenna P, Masyn S, Willems A, De Paepe A, Rutten R, Mazarati JB, et al. Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in Rwanda. Hum Vaccines Immunotherapeutics. 2021;17(9):3192\u2013202.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"12442_CR107","doi-asserted-by":"crossref","unstructured":"Khan FMA, Hasan MM, Kazmi Z, Dos Santos Costa AC, Aborode AT, Ahmad S, et al. Ebola and COVID-19 in Democratic Republic of Congo: grappling with two plagues at once. Trop Med And Health. 2021;49(1).","DOI":"10.1186\/s41182-021-00356-6"},{"key":"12442_CR108","doi-asserted-by":"publisher","first-page":"103958","DOI":"10.1016\/j.amsu.2022.103958","volume":"79","author":"J Sun","year":"2022","unstructured":"Sun J, Uwishema O, Kassem H, Abbass M, Uweis L, Rai A, et al. Ebola virus outbreak returns to the Democratic Republic of Congo: an urgent rising concern. Ann of Med Surg. 2022;79:103958.","journal-title":"Ann of Med Surg"},{"key":"12442_CR109","doi-asserted-by":"crossref","unstructured":"Vossler H, Akilimali P, Pan Y, Khudabukhsh WR, Kenah E, Rempa\u0142a GA. Analysis of individual-level data from 2018\u20132020 Ebola outbreak in Democratic Republic of the Congo. Sci Rep. 2022;12(1).","DOI":"10.1038\/s41598-022-09564-4"},{"key":"12442_CR110","doi-asserted-by":"crossref","unstructured":"Wolf J, Bruno S, Eichberg M, Jannat R, Rudo S, Vanrheenen S, et al. Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens. npj Vaccines. 2020;5(1).","DOI":"10.1038\/s41541-020-0204-7"},{"key":"12442_CR111","doi-asserted-by":"crossref","unstructured":"Benavides JA, Caparr\u00f3s C, Da Silva RM, Lembo T, Tem Dia P, Hampson K, et al. The power of music to prevent and control emerging Infectious diseases. Front Med. 2021;8.","DOI":"10.3389\/fmed.2021.756152"},{"issue":"11","key":"12442_CR112","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.drudis.2021.06.019","volume":"26","author":"R Amaral","year":"2021","unstructured":"Amaral R, Torre C, Rocha J, Sepodes B. Ebola outbreaks: a stress test of the preparedness of medicines regulatory systems for public health crises. Drug Discov Today. 2021;26(11):2608\u201318.","journal-title":"Drug Discov Today"},{"key":"12442_CR113","doi-asserted-by":"crossref","unstructured":"Gruber MF, Rubin S, Krause PR. Approaches to demonstrating the effectiveness of filovirus vaccines: lessons from Ebola and COVID-19. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1109486"},{"key":"12442_CR114","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.coviro.2021.10.007","volume":"51","author":"AN Pinski","year":"2021","unstructured":"Pinski AN, Messaoudi I. Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity. Curr Opin In Virol. 2021;51:179\u201389.","journal-title":"Curr Opin In Virol"},{"key":"12442_CR115","doi-asserted-by":"crossref","unstructured":"Escudero-P\u00e9rez B, Lawrence P, Castillo-Olivares J. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1156758"},{"issue":"6","key":"12442_CR116","doi-asserted-by":"publisher","first-page":"e16813","DOI":"10.1016\/j.heliyon.2023.e16813","volume":"9","author":"RS Singh","year":"2023","unstructured":"Singh RS, Singh A, Masih GD, Batra G, Sharma AR, Joshi R, et al. A comprehensive insight on the challenges for COVID-19 vaccine: a lesson learnt from other viral vaccines. Heliyon. 2023;9(6):e16813.","journal-title":"Heliyon"},{"issue":"10","key":"12442_CR117","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/microorganisms8101473","volume":"8","author":"AN Pinski","year":"2020","unstructured":"Pinski AN, Messaoudi I. To B or not to B: mechanisms of protection conferred by rVSV-EBOV-GP and the roles of innate and adaptive immunity. Microorganisms. 2020;8(10):1473.","journal-title":"Microorganisms"},{"issue":"2","key":"12442_CR118","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2666-5247(20)30198-1","volume":"2","author":"RF Grais","year":"2021","unstructured":"Grais RF, Kennedy SB, Mahon BE, Dubey SA, Grant-Klein RJ, Liu K, et al. Estimation of the correlates of protection of the rVSV\u0394G-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2\/3 clinical trials. The Lancet Microbe. 2021;2(2):e70\u20138.","journal-title":"The Lancet Microbe"},{"key":"12442_CR119","doi-asserted-by":"publisher","first-page":"1215302","DOI":"10.3389\/fimmu.2023.1215302","volume":"14","author":"C McLean","year":"2023","unstructured":"McLean C, Dijkman K, Gaddah A, Keshinro B, Katwere M, Douoguih M, et al. Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans. Front Immunol. 2023;14:1215302.","journal-title":"Front Immunol"},{"issue":"4","key":"12442_CR120","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1473-3099(20)30736-2","volume":"21","author":"R Thom","year":"2021","unstructured":"Thom R, Tipton T, Strecker T, Hall Y, Akoi Bore J, Maes P, et al. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. The Lancet Infect Dis. 2021;21(4):507\u201316.","journal-title":"The Lancet Infect Dis"},{"issue":"9","key":"12442_CR121","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/v12090915","volume":"12","author":"T Koch","year":"2020","unstructured":"Koch T, Rottstegge M, Ruibal P, Gomez-Medina S, Nelson EV, Escudero-P\u00e9rez B, et al. Ebola virus disease survivors show more efficient antibody immunity than vaccinees Despite similar levels of circulating immunoglobulins. Viruses. 2020;12(9):915.","journal-title":"Viruses"},{"issue":"7","key":"12442_CR122","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/pathogens11070800","volume":"11","author":"CR Dhanya","year":"2022","unstructured":"Dhanya CR, Shailaja A, Mary AS, Kandiyil SP, Savithri A, Lathakumari VS, et al. RNA Viruses, pregnancy and vaccination: emerging Lessons from COVID-19 and Ebola virus disease. Pathogens. 2022;11(7):800.","journal-title":"Pathogens"},{"issue":"7846","key":"12442_CR123","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-020-03146-y","volume":"590","author":"C Adaken","year":"2021","unstructured":"Adaken C, Scott JT, Sharma R, Gopal R, Dicks S, Niazi S, et al. Ebola virus antibody decay-stimulation in a high proportion of survivors. Nature. 2021;590(7846):468\u201372.","journal-title":"Nature"},{"issue":"2","key":"12442_CR124","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/biostatistics\/kxaa037","volume":"23","author":"DA Follmann","year":"2022","unstructured":"Follmann DA, Dodd L. Immune correlates analysis using vaccinees from test negative designs. Biostatistics. 2022;23(2):507\u201321.","journal-title":"Biostatistics"},{"issue":"6","key":"12442_CR125","doi-asserted-by":"publisher","first-page":"e2118895119","DOI":"10.1073\/pnas.2118895119","volume":"119","author":"NA Hoff","year":"2022","unstructured":"Hoff NA, Bratcher A, Kelly JD, Musene K, Kompany JP, Kabamba M, et al. Immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo. Proc Natl Acad Sci. 2022;119(6):e2118895119.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"12442_CR126","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.cmi.2023.08.026","volume":"29","author":"A Huttner","year":"2023","unstructured":"Huttner A, Agnandji ST, Engler O, Hooper JW, Kwilas S, Ricks K, et al. Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability. Clin Microbiol And Infect. 2023;29(12):1587\u201394.","journal-title":"Clin Microbiol And Infect"},{"key":"12442_CR127","doi-asserted-by":"crossref","unstructured":"Ficko C, Conan P-L, Cabon M, Gominet M, Lamand V, Andriamanantena D, et al. Safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: experience from a French pretravel clinic. J Travel Med. 2022.","DOI":"10.1093\/jtm\/taac079"},{"key":"12442_CR128","doi-asserted-by":"crossref","unstructured":"Ishola D, Bah OM, Bangalie FS, Bangura A, David I, Deen GF, et al. Asymptomatic malaria infection and the immune response to the 2-dose Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen in adults and children. Clin Infect Dis. 2022.","DOI":"10.1093\/cid\/ciac209"},{"issue":"8","key":"12442_CR129","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/vaccines11081317","volume":"11","author":"D Manno","year":"2023","unstructured":"Manno D, Patterson C, Drammeh A, Tetteh K, Kroma MT, Otieno GT, et al. The effect of previous exposure to malaria infection and clinical malaria episodes on the immune response to the two-dose Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen. Vaccines. 2023;11(8):1317.","journal-title":"Vaccines"},{"key":"12442_CR130","doi-asserted-by":"crossref","unstructured":"Carnino L, Vetter P, Peyraud N, Aebischer-Perone S, Chappuis F, Huttner A, et al. Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study. J Travel Med. 2021;28(8).","DOI":"10.1093\/jtm\/taab086"},{"issue":"8","key":"12442_CR131","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.vaccine.2023.01.059","volume":"41","author":"V Raabe","year":"2023","unstructured":"Raabe V, Lai L, Morales J, Xu Y, Rouphael N, Davey RT, et al. Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSV\u0394G-ZEBOV-GP). Vaccine. 2023;41(8):1513\u201323.","journal-title":"Vaccine"},{"key":"12442_CR132","doi-asserted-by":"crossref","unstructured":"Cross RW, Bornholdt ZA, Prasad AN, Geisbert JB, Borisevich V, Agans KN, et al. Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment. Nat Commun. 2020;11(1).","DOI":"10.1038\/s41467-020-17446-4"},{"issue":"2","key":"12442_CR133","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmi.2022.09.014","volume":"29","author":"AB Dagens","year":"2023","unstructured":"Dagens AB, Rojek A, Sigfrid L, Pl\u00fcddemann A. The diagnostic accuracy of rapid diagnostic tests for Ebola virus disease: a systematic review. Clin Microbiol And Infect. 2023;29(2):171\u201381.","journal-title":"Clin Microbiol And Infect"},{"issue":"2","key":"12442_CR134","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3934\/mbe.2022082","volume":"19","author":"R Seck","year":"2021","unstructured":"Seck R, Ngom D, Ivorra B, Ramos \u00c1M. An optimal control model to design strategies for reducing the spread of the Ebola virus disease. Math Biosci And Eng. 2021;19(2):1746\u201374.","journal-title":"Math Biosci And Eng"},{"issue":"1","key":"12442_CR135","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21010\/ajid.v15i1.2","volume":"15","author":"QO Ahman","year":"2021","unstructured":"Ahman QO, David O, Chukwuma AC, Ugochukwu ND, Ezike MGC. Transmission dynamics of EBOLA virus disease with vaccine, condom use, quarantine, isolation and treatment drug. Afr J Infect Dis. 2021;15(1):10\u201323.","journal-title":"Afr J Infect Dis"},{"issue":"1","key":"12442_CR136","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21010\/Ajidv17i1.2","volume":"17","author":"GCE Mbah","year":"2023","unstructured":"Mbah GCE, Onah IS, Ahman QO, Collins OC, Asogwa CC, Okoye C. Mathematical modelling approach of the study of EBOLA virus disease transmission dynamics in a developing country. Afr J Infect Dis. 2023;17(1):10\u201326.","journal-title":"Afr J Infect Dis"},{"key":"12442_CR137","doi-asserted-by":"publisher","first-page":"104186","DOI":"10.1016\/j.ebiom.2022.104186","volume":"82","author":"S Ravichandran","year":"2022","unstructured":"Ravichandran S, Khurana S. Ebola-detect: a differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies. eBiomedicine. 2022;82:104186.","journal-title":"eBiomedicine"},{"issue":"51","key":"12442_CR138","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1016\/j.vaccine.2021.10.071","volume":"39","author":"NA Hoff","year":"2021","unstructured":"Hoff NA, Bratcher A, Mukadi P, Ahuka S, Kabamba M, Musene K, et al. Increasing Ebola transmission behaviors 6 months post-vaccination: comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo. Vaccine. 2021;39(51):7464\u201369.","journal-title":"Vaccine"},{"issue":"7","key":"12442_CR139","doi-asserted-by":"publisher","first-page":"e0254044","DOI":"10.1371\/journal.pone.0254044","volume":"16","author":"P Chen","year":"2021","unstructured":"Chen P, Fan W, Guo X. A hybrid simulation model to study the impact of combined interventions on Ebola epidemic. PLoS One. 2021;16(7):e0254044.","journal-title":"PLoS One"},{"issue":"5","key":"12442_CR140","doi-asserted-by":"publisher","first-page":"e009240","DOI":"10.1136\/bmjgh-2022-009240","volume":"7","author":"C Eggers","year":"2022","unstructured":"Eggers C, Martel L, Dismer A, Kallay R, Sayre D, Choi M, et al. Implementing a DHIS2 Ebola virus disease module during the 2021 Guinea Ebola outbreak. BMJ Global Health. 2022;7(5):e009240.","journal-title":"BMJ Global Health"},{"issue":"8","key":"12442_CR141","doi-asserted-by":"publisher","first-page":"e28573","DOI":"10.2196\/28573","volume":"23","author":"T Zola Matuvanga","year":"2021","unstructured":"Zola Matuvanga T, Johnson G, Larivi\u00e8re, Esanga Longomo E, Matangila J, Maketa V, et al. Use of iris scanning for biometric recognition of healthy adults participating in an Ebola vaccine Trial in the Democratic Republic of the Congo: mixed methods study. J Med Internet Res. 2021;23(8):e28573.","journal-title":"J Med Internet Res"},{"key":"12442_CR142","doi-asserted-by":"crossref","unstructured":"Marks M, Lal S, Brindle H, Gsell P-S, Macgregor M, Stott C, et al. Electronic data management for vaccine trials in low resource settings: upgrades, scalability, and impact of ODK. Front Public Health. 2021;9.","DOI":"10.3389\/fpubh.2021.665584"},{"issue":"4","key":"12442_CR143","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1473-3099(21)00155-9","volume":"21","author":"P Adepoju","year":"2021","unstructured":"Adepoju P. Ebola and COVID-19 in DR Congo and Guinea. The Lancet Infect Dis. 2021;21(4):461.","journal-title":"The Lancet Infect Dis"},{"issue":"11","key":"12442_CR144","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1080\/21645515.2021.1948785","volume":"17","author":"TY Akintunde","year":"2021","unstructured":"Akintunde TY, Musa TH, Musa HH, Chen S, Ibrahim E, Muhideen S, et al. Mapping the global research output on Ebola vaccine from research indexed in web of science and scopus: a comprehensive bibliometric analysis. Hum Vaccines Immunotherapeutics. 2021;17(11):4246\u201358.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"1","key":"12442_CR145","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/20476965.2021.1992300","volume":"12","author":"C Decouttere","year":"2023","unstructured":"Decouttere C, Vandaele N, De Boeck K, Banzimana S. A systems-based framework for immunisation system design: six loops, three flows, two paradigms. Health Syst. 2023;12(1):36\u201351.","journal-title":"Health Syst"},{"issue":"suppl 2","key":"12442_CR146","doi-asserted-by":"publisher","first-page":"ii62","DOI":"10.1093\/heapol\/czr049","volume":"27","author":"HED Burchett","year":"2012","unstructured":"Burchett HED, Mounier-Jack S, Griffiths UK, Mills AJ. National decision-making on adopting new vaccines: a systematic review. Health Policy Plann. 2012;27(suppl 2):ii62\u201376.","journal-title":"Health Policy And Plann"},{"issue":"3","key":"12442_CR147","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/heapol\/czac092","volume":"38","author":"D Guillaume","year":"2023","unstructured":"Guillaume D, Meyer D, Waheed D-EN, Schlieff M, Muralidharan K, Chou VB, et al. Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review. Health Policy Plann. 2023;38(3):363\u201376.","journal-title":"Health Policy And Plann"},{"issue":"1","key":"12442_CR148","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/vaccines12010024","volume":"12","author":"D Guttieres","year":"2023","unstructured":"Guttieres D, Diepvens C, Decouttere C, Vandaele N. Modeling supply and demand dynamics of vaccines against epidemic-prone pathogens: case study of Ebola virus disease. Vaccines. 2023;12(1):24.","journal-title":"Vaccines"},{"issue":"3","key":"12442_CR149","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/vaccines13030269","volume":"13","author":"S Fousseni","year":"2025","unstructured":"Fousseni S, Ngangue P, Barro A, Ramde SW, Bihina LT, Ngoufack MN, et al. Navigating the road to immunization equity: systematic review of challenges in introducing new vaccines into Sub-Saharan Africa\u2019s health systems. Vaccines. 2025;13(3):269.","journal-title":"Vaccines"},{"key":"12442_CR150","volume-title":"Who global framework to prepare for country introduction of new TB vaccines for adults and adolescents","author":"WHO","year":"2023","unstructured":"WHO. Who global framework to prepare for country introduction of new TB vaccines for adults and adolescents. 2023."},{"key":"12442_CR151","unstructured":"WHO. Highlights from the meeting of the Strategic Advisory group of Experts (SAGE) on immunization. 2025 2025 March 10\u201313."},{"key":"12442_CR152","unstructured":"World Health Organization. Disease outbreak news - Sudan virus disease - Uganda 2025 [Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON556."},{"key":"12442_CR153","unstructured":"WHO. Disease outbreak news: Sudan virus disease - Uganda 2025 [Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON558#:~:text=Since%20the%20outbreak%20of%20Sudan%20virus%20disease%20%28SVD%29,%28two%20confirmed%20and%20two%20probable%29%20have%20been%20reported."},{"issue":"1","key":"12442_CR154","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s10393-016-1100-5","volume":"13","author":"KH Jacobsen","year":"2016","unstructured":"Jacobsen KH, Aguirre AA, Bailey CL, Baranova AV, Crooks AT, Croitoru A, et al. Lessons from the Ebola outbreak: action Items for emerging Infectious disease preparedness and response. EcoHealth. 2016;13(1):200\u201312.","journal-title":"EcoHealth"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12442-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:03:58Z","timestamp":1769684638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12442-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12442"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12442-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information (optional)"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}